Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.

PERSONAL PROFESSIONAL

en

Ways to trade

Trading platforms

Trading info

Fraud prevention

Trading tools

Our markets

Market updates

Market analysis

Pricing

Charges and fees

Our business model

Markets pricing

For trading beginners

Trading essentials

Risk management

For experienced traders

Trading strategies

Trading psychology

Technical analysis

Market analysis

About us

Why Capital.com?

Leadership team

Whitepaper CCUK

Get help

Client vulnerability

Terms and policies

Work for us

Tech recruitment

PERSONAL PROFESSIONAL

en

Home Markets SharesAstellas Pharma Inc.

Trade Astellas Pharma Inc. - 4503 CFD

Astellas Pharma Inc. Company profile

About Astellas Pharma Inc

Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Astellas Pharma Inc revenues increased 5% to Y992.29B. Net income applicable to common stockholders decreased less than 1% to Y132.49B. Revenues reflect Sales of Pharmaceuticals segment increase of 6% to Y971.11B, Other Business segment increase of 33% to Y14.07B, Americas segment increase of 15% to Y407.94B, Estabridge segment increase of 10% to Y239.22B.

Equity composition

04/2005, Company merged with Fujisawa Pharmaceutical Co., Ltd. & Name Changed from Yamanouchi Pharmaceutical Co., Ltd. FY'08 1Q&Q3 WAS & DWAS estimated and WAS used as O/S. FY'09 Q3,12 Q2 DWAS estimated.

Latest shares articles

GBP/USD in focus ahead of FED and BOE meetings

Both the Federal Reserve and Bank of England will deliver their updated monetary policies this week, with GBP/USD likely to experience increased momentum.

17:16, 17 December 2024

The markets expect FOMC to cut but outlook in 2025 is less certain

Markets expect a 25bp rate cut at the FOMC meeting on December 18, 2024, amid strong U.S. economic data. However, the outlook for 2025 remains uncertain as inflation and growth trends evolve.

12:56, 17 December 2024

Financial data on the monitor

Projected US interest rates in 5 years: Third party round up

As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?

10:09, 13 December 2024

Street in City of London with Royal Exchange, Bank of England and new modern skyscrapers

Projected UK interest rates in 5 years

Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?

12:58, 12 December 2024

Read our reviews to find out more about us

Read the feedback from our clients around the world.

Very trustworthy and affordable for any size trades

It is very easy to connect with TradingView but the web interface is also great.

Easy to use and great support. Been using it for 2 years already and still happy

Capital.com is one of the best stock trading platforms I’ve used. The UX and UI on both the mobile app and web platform are outstanding, making it incredibly easy to navigate. They’ve built a vibrant community of traders and investors, and their UAE team really stands out for delivering an exceptional trading experience.

Best broker!! they call you to see if you need any help. The app is good and nice better than the rest

Iuliia Salivon

Great app! I requested some features to be added, such as analysis tools, and they delivered. Amazing job! The agents are always helpful and reply quickly. It’s not 5 stars because, at times, some less experienced agents may say it’s impossible to fulfill the request or fix the problem while another agent, like Angel, quickly escalated the issue to the necessary team/person/department and resolved it

This is an excellent platform. The stop loss and take profit work very well; however, when the changes are very fast like at the beginning of the session, the stop loss does not work. If this defect is corrected it will be the perfect platform.

adenysenko24

-Nice -Easy to use - Beautiful Interface

I think I'm new in this trading platform, but I find it affordable and most reliable. To be honest I'm not fully experienced trader, but with very limited knowledge of trading I try learn as much as I can by trying out different platforms see if can make money. My interests growing in you platform, l like news updates you also short videos on YouTube, other propaganda, poster and many more. I will see what happens in the coming months. Thanks capital team.

John Fallows

Gives you options to start learning how too do it as it gives you a demo option to learn from your mistakes

Efficiency. When creating the account, it was smooth, efficient from start to finish. Verification of documents also was done the same day, unlike other platforms where you have to wait a day or two.

Osondu Paul

From what I'm seeing it's cool Mixing it with trading view it's perfect... I didn't give it 5 star yet cos I still need to use it for some time

Showing our 4 & 5 star reviews

4.6

Ratings and Reviews

4.7

Ratings and Reviews

4.5

4.3

Ready to join a leading broker?

Join our community of traders worldwide

1. Create your account2. Make your first deposit3. Start trading